XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Cash flows from operating activities:              
Net income (loss) $ (1,974) $ (9,537) $ (2,515) $ (1,247) $ (11,511) $ (3,762)  
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:              
Depreciation, depletion, accretion, and amortization         4,360 5,313  
Impairment of oil and natural gas properties 0   0   5,419 0  
Deferred income taxes         0 (288)  
Total commodity derivatives (gains) losses, net         1,493 (1,208)  
Commodity derivative settlements received (paid)         525 (494)  
(Gains) losses on marketable equity securities         5 16  
Impairment and loss on real estate held for sale         11 0  
Amortization of debt issuance costs         24 24  
Stock-based compensation         675 1,334  
Right of use asset amortization         81 95  
Changes in operating assets and liabilities:              
Oil and natural gas sales receivable         434 479  
Other assets         (372) 240  
Accounts payable and accrued liabilities         (372) (164)  
Accrued compensation and benefits         (265) (500)  
Revenue and royalties payable         (34) 478  
Payments on operating lease liability         (89) (102)  
Payments of asset retirement obligations         (58) (52)  
Net cash provided by (used in) operating activities         326 1,409  
Cash flows from investing activities:              
Acquisition of helium properties         (2,213) 0  
Oil and natural gas capital expenditures         (667) (2,402)  
Property and equipment expenditures         (202) (373)  
Proceeds from sale of oil and natural gas properties, net         247 0  
Proceeds from sale of real estate assets         139 0  
Net cash provided by (used in) investing activities         (2,696) (2,775)  
Cash flows from financing activities:              
Borrowings on credit facility         2,000 0  
Payments on insurance premium finance note         (62) (286)  
Shares withheld to settle tax withholding obligations for restricted stock awards         (132) (151)  
Dividends paid         0 (1,192)  
Repurchases of common stock         (564) (241)  
Net cash provided by (used in) financing activities         1,242 (1,870)  
Net (decrease) increase in cash and equivalents         (1,128) (3,236)  
Cash and equivalents, beginning of period   $ 3,351   $ 4,411 3,351 4,411 $ 4,411
Cash and equivalents, end of period $ 2,223   $ 1,175   $ 2,223 $ 1,175 $ 3,351